In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon ß-1a differed from standard care for in-hospital mortality.
Ann Intern Med
; 174(2): JC17, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-1526980
ABSTRACT
SOURCE CITATION Pan H, Peto R, Henao-Restrepo AM, et al. Repurposed antiviral drugs for Covid-19-interim WHO Solidarity Trial results. N Engl J Med. 2020. [Epub ahead of print.] 33264556.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Hospital Mortality
/
COVID-19
Type of study:
Prognostic study
/
Randomized controlled trials
/
Reviews
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Ann Intern Med
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS